2021 press releases
- Gustave Roussy and LXRepair announce a partnership for personalized radiotherapy of cancer
Press release, 21 october 2021 - SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe
Press release, 5 october 2021 - New startup Aglaia Therapeutics raises €4M in seed funding to overcome resistance in oncology targeted therapies
Press release, 27 september 2021 - ESMO 2021 - Artificial Intelligence predicts the risk of recurrence for women with the most common breast cancer
Press release, 21 september 2021 - ESMO 2021 - First scientific evidence for effectiveness of a treatment for rare neuroendocrine tumours.
Press release, 20 september 2021 - ESMO 2021 - Lung cancers: a vaccine demonstrates encouraging effects in reviving patient immunity.
Press release, 20 september 2021 - Speeding up Breast Cancer Diagnosis in Egypt: GE Healthcare, Gustave Roussy and the Egypt Ministry of Health Partner to Create Rapid Breast Cancer Diagnosis Clinics
Press release, 7 september 2021 - Professor Fabrice Barlesi is appointed General Director of Gustave Roussy
Press release, 30 july 2021 - Creation of a patient-centered biocluster in oncology
Press release, 30 june 2021 - ORPHELIA Pharma and Gustave Roussy announce issuance of European Patent covering Kimozo®, the first oral liquid formulation of temozolomide
Press release, 16 june 2021 - ASCO 2021 : Prostate cancer with metastases at the time of diagnosis A combination of two hormone therapies and a single chemotherapy doubles progression-free survival
Press release, 8 june 2021 - ASCO 2021 : Metastatic or recurrent cancer of the uterine cervix: encouraging results with second generation immunotherapy
Press release, 4 june 2021 - ASCO 2021: Relapsed or refractory acute myeloid leukaemia: hope for complete remission with targeted oral therapy
Press release, 4 june 2021 - Gustave Roussy joins the Worldwide Innovative Network (WIN) in personalized cancer medicine consortium- WIN Consortium
Press release, 29 april 2021 - Ovarian cancer drug offers new genetically targeted approach against range of cancers
Press release, 23 april 2021
Catégorie de la page:
